» Articles » PMID: 17314394

Epigenetic Reprogramming of OCT4 and NANOG Regulatory Regions by Embryonal Carcinoma Cell Extract

Overview
Journal Mol Biol Cell
Date 2007 Feb 23
PMID 17314394
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Analyses of molecular events associated with reprogramming somatic nuclei to pluripotency are scarce. We previously reported the reprogramming of epithelial cells by extract of undifferentiated embryonal carcinoma (EC) cells. We now demonstrate reprogramming of DNA methylation and histone modifications on regulatory regions of the developmentally regulated OCT4 and NANOG genes by exposure of 293T cells to EC cell extract. OCT4 and NANOG are transcriptionally up-regulated and undergo mosaic cytosine-phosphate-guanosine demethylation. OCT4 demethylation occurs as early as week 1, is enhanced by week 2, and is most prominent in the proximal promoter and distal enhancer. Targeted OCT4 and NANOG demethylation does not occur in 293T extract-treated cells. Retinoic acid-mediated differentiation of reprogrammed cells elicits OCT4 promoter remethylation and transcriptional repression. Chromatin immunoprecipitation analyses of lysines K4, K9, and K27 of histone H3 on OCT4 and NANOG indicate that primary chromatin remodeling determinants are acetylation of H3K9 and demethylation of dimethylated H3K9. H3K4 remains di- and trimethylated. Demethylation of trimethylated H3K9 and H3K27 also occurs; however, trimethylation seems more stable than dimethylation. We conclude that a central epigenetic reprogramming event is relaxation of chromatin at loci associated with pluripotency to create a conformation compatible with transcriptional activation.

Citing Articles

Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors.

Schepisi G, Gianni C, Cursano M, Galla V, Menna C, Casadei C Front Immunol. 2023; 14:1118610.

PMID: 36860862 PMC: 9968831. DOI: 10.3389/fimmu.2023.1118610.


UCH-L1 and UCH-L3 regulate the cancer stem cell-like properties through PI3 K/Akt signaling pathway in prostate cancer cells.

Lee J, Lim Y, Kim J Anim Cells Syst (Seoul). 2021; 25(5):312-322.

PMID: 34745437 PMC: 8567960. DOI: 10.1080/19768354.2021.1987320.


Hydrogen sulfide facilitates reprogramming and trans-differentiation in 3D dermal fibroblast.

Ostrakhovitch E, Akakura S, Tabibzadeh S PLoS One. 2020; 15(11):e0241685.

PMID: 33180827 PMC: 7660576. DOI: 10.1371/journal.pone.0241685.


Nanosecond pulsed electric fields enhance mesenchymal stem cells differentiation via DNMT1-regulated OCT4/NANOG gene expression.

Li K, Ning T, Wang H, Jiang Y, Zhang J, Ge Z Stem Cell Res Ther. 2020; 11(1):308.

PMID: 32698858 PMC: 7374836. DOI: 10.1186/s13287-020-01821-5.


Transient inhibition of mTOR in human pluripotent stem cells enables robust formation of mouse-human chimeric embryos.

Hu Z, Li H, Jiang H, Ren Y, Yu X, Qiu J Sci Adv. 2020; 6(20):eaaz0298.

PMID: 32426495 PMC: 7220352. DOI: 10.1126/sciadv.aaz0298.


References
1.
Taranger C, Noer A, Sorensen A, Hakelien A, Boquest A, Collas P . Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol Biol Cell. 2005; 16(12):5719-35. PMC: 1289416. DOI: 10.1091/mbc.e05-06-0572. View

2.
Gurdon J, Byrne J, Simonsson S . Nuclear reprogramming and stem cell creation. Proc Natl Acad Sci U S A. 2003; 100 Suppl 1:11819-22. PMC: 304092. DOI: 10.1073/pnas.1834207100. View

3.
Armstrong L, Lako M, Dean W, Stojkovic M . Epigenetic modification is central to genome reprogramming in somatic cell nuclear transfer. Stem Cells. 2005; 24(4):805-14. DOI: 10.1634/stemcells.2005-0350. View

4.
Azuara V, Perry P, Sauer S, Spivakov M, Jorgensen H, John R . Chromatin signatures of pluripotent cell lines. Nat Cell Biol. 2006; 8(5):532-8. DOI: 10.1038/ncb1403. View

5.
Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View